TrialAnnals of transplantation2022

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipients with Hepatocellular Carcinoma.

Gonzalo Sapisochin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.